Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

Athira Pharma has been on a bumpy road in recent years, and now the company is restructuring and shedding weight to try to ...

The first phase of what eventually will be the country’s largest truck stop is set to open Oct. 1 off Interstate 90 in West ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

Structure Therapeutics (NASDAQ:GPCR), and Terns Pharmaceuticals (NASDAQ:TERN), which are all developing oral pills as weight loss treatments, are trading higher Friday following disappointing results ...

The next morning, Sept. 16, Hawaiian Volcano Observatory scientists on a helicopter overflight confirmed that a small ...

Plus: LiquidStack raises $20 Million in Series B extension investment, HEST Investments secures $1.8 million SPV investment ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

For the IBD and MarketWatch list of the Most Trusted Financial Companies in 2024, we asked more than 7,000 survey participants for their opinion of the financial soundness of the financial companies ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...